-
1
-
-
36249025723
-
Autophagy: Process and function [J]
-
Mizushima, N. Autophagy: process and function [J]. Genes Dev, 2007,21(22):2861-2873.
-
(2007)
Genes Dev
, vol.21
, Issue.22
, pp. 2861-2873
-
-
Mizushima, N.1
-
2
-
-
7744235672
-
Death by design: Apoptosis, necrosis and autophagy [J]
-
Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy [J]. Curt Opin Cell Biol, 2004,16 (6): 663-669.
-
(2004)
Curt Opin Cell Biol
, vol.16
, Issue.6
, pp. 663-669
-
-
Edinger, A.L.1
Thompson, C.B.2
-
3
-
-
60149098492
-
The pivotal role of c-Ju n NH2- terminal kinase-m ediated Beclin 1 expression during anticancer agents-in duced autophagy in cancer cells [J]
-
Li DD, Wang LL, Deng R, et al. The pivotal role of c-Ju n NH2- terminal kinase-m ediated Beclin 1 expression during anticancer agents-in duced autophagy in cancer cells [J]. Oncogene, 2009,28(6):886-898.
-
(2009)
Oncogene
, vol.28
, Issue.6
, pp. 886-898
-
-
Li, D.D.1
Wang, L.L.2
Deng, R.3
-
4
-
-
44449093751
-
Differential expression of autophagy in Hodgkin lymphoma cells treated with various anti-ca ncer drugs [J]
-
Oehadian A, Koide N, Hassan F, et al. Differential expression of autophagy in Hodgkin lymphoma cells treated with various anti-ca ncer drugs [J]. Acta Med Indones, 2007,39(4):153-156.
-
(2007)
Acta Med Indones
, vol.39
, Issue.4
, pp. 153-156
-
-
Oehadian, A.1
Koide, N.2
Hassan, F.3
-
5
-
-
21244437063
-
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF [J]
-
Sumpter K, Harper-W ynne C, Cunningham D, et al. Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF [J]. Br J Cancer, 2005,92(11):1976-1983.
-
(2005)
Br J Cancer
, vol.92
, Issue.11
, pp. 1976-1983
-
-
Sumpter, K.1
Harper-W ynne, C.2
Cunningham, D.3
-
6
-
-
38049047178
-
Capecitabine and oxaliplatin for advanced esophagogastric cancer [J]
-
Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer [J]. N Engl J Med, 2008,358(1):36-46.
-
(2008)
N Engl J Med
, vol.358
, Issue.1
, pp. 36-46
-
-
Cunningham, D.1
Starling, N.2
Rao, S.3
-
7
-
-
33846794896
-
Autophagy inhibition enhances therapy-in duced apoptosis in a Myc-in duced model of lymphoma [J]
-
Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-in duced apoptosis in a Myc-in duced model of lymphoma [J]. J Clin Invest, 2007,117(2):326-336.
-
(2007)
J Clin Invest
, vol.117
, Issue.2
, pp. 326-336
-
-
Amaravadi, R.K.1
Yu, D.2
Lum, J.J.3
-
8
-
-
77649286874
-
Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy [J]
-
Ren JH, He WS, Nong L, et al. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy [J]. Cancer Biother Radiopharm, 2010,25(1):75-80.
-
(2010)
Cancer Biother Radiopharm
, vol.25
, Issue.1
, pp. 75-80
-
-
Ren, J.H.1
He, W.S.2
Nong, L.3
-
9
-
-
77953289524
-
Inhibition of autophagy augments 5-flu orouracil chemotherapy in human colon cancer in vitro and in vivo model [J]
-
Li J, Hou N, Faried A, et al. Inhibition of autophagy augments 5-flu orouracil chemotherapy in human colon cancer in vitro and in vivo model [J]. Eur J Cancer, 2010,46(10):1900-1909.
-
(2010)
Eur J Cancer
, vol.46
, Issue.10
, pp. 1900-1909
-
-
Li, J.1
Hou, N.2
Faried, A.3
-
10
-
-
60449092595
-
Inhibition of autophagy by 3-M A enhances the effect of 5-FU -in duced apoptosis in colon cancer cells [J]
-
Li J, Hou N, Faried A, et al. Inhibition of autophagy by 3-M A enhances the effect of 5-FU -in duced apoptosis in colon cancer cells [J]. Ann Surg Oncol, 2009,16(3):761-771.
-
(2009)
Ann Surg Oncol
, vol.16
, Issue.3
, pp. 761-771
-
-
Li, J.1
Hou, N.2
Faried, A.3
-
11
-
-
79952244140
-
Inhibition of autophagy by 3-M A potentiates cisplatin-in duced apoptosis in esophageal squamous cell carcinoma cells [J]
-
Liu D, Yang Y, Liu Q, et al. Inhibition of autophagy by 3-M A potentiates cisplatin-in duced apoptosis in esophageal squamous cell carcinoma cells [J]. Med Oncol, 2011,28 (1): 105-111.
-
(2011)
Med Oncol
, vol.28
, Issue.1
, pp. 105-111
-
-
Liu, D.1
Yang, Y.2
Liu, Q.3
-
12
-
-
67949104883
-
Autophagy in tumor suppression and promotion [J]
-
Brech A, Ahlquist T, Lothe R A, et al. Autophagy in tumor suppression and promotion [J]. Mol Oncol, 2009,3(4):366-375.
-
(2009)
Mol Oncol
, vol.3
, Issue.4
, pp. 366-375
-
-
Brech, A.1
Ahlquist, T.2
Lothe, R.A.3
-
13
-
-
60749100304
-
Oxaliplatin enhances TRAIL- induced apoptosis in gastric cancer cells by CBL-re gulated death receptor redistribution in lipid rafts [J]
-
Xu L, Qu X, Zhang Y, et al. Oxaliplatin enhances TRAIL- induced apoptosis in gastric cancer cells by CBL-re gulated death receptor redistribution in lipid rafts [J]. FEBS Lett, 2009,583(5):943-948.
-
(2009)
FEBS Lett
, vol.583
, Issue.5
, pp. 943-948
-
-
Xu, L.1
Qu, X.2
Zhang, Y.3
-
14
-
-
77954556955
-
Chloroquine potentiates the anti-ca ncer effect of 5-flu orouracil on colon cancer cells [J]
-
Sasaki K, Tsuno NH, Sunami E, et al. Chloroquine potentiates the anti-ca ncer effect of 5-flu orouracil on colon cancer cells [J]. BMC Cancer, 2010,10:370.
-
(2010)
BMC Cancer
, vol.10
, pp. 370
-
-
Sasaki, K.1
Tsuno, N.H.2
Sunami, E.3
-
15
-
-
1542328927
-
Structure, regulation and function of PKB/AKT-a major therapeutic target [J]
-
Hanada M, Feng J, Hemmings BA. Structure, regulation and function of PKB/AKT-a major therapeutic target [J]. Biochim Biophys Acta, 2004,1697(1-2):3-16.
-
(2004)
Biochim Biophys Acta
, vol.1697
, Issue.1-2
, pp. 3-16
-
-
Hanada, M.1
Feng, J.2
Hemmings, B.A.3
-
16
-
-
71549161146
-
Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy [J]
-
Fu L, Kim YA, Wang X, et al. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy [J]. Cancer Res, 2009,69(23):8967-8976.
-
(2009)
Cancer Res
, vol.69
, Issue.23
, pp. 8967-8976
-
-
Fu, L.1
Kim, Y.A.2
Wang, X.3
-
17
-
-
77951217696
-
Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5- fluorouracil in colon cancer cells [J]
-
Bijnsdorp IV, Peters GJ, Temmink OH, et al. Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5- fluorouracil in colon cancer cells [J]. Int J Cancer, 2010,126 (10):2457-2468.
-
(2010)
Int J Cancer
, vol.126
, Issue.10
, pp. 2457-2468
-
-
Bijnsdorp, I.V.1
Peters, G.J.2
Temmink, O.H.3
-
18
-
-
77955714496
-
Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-in duced apoptosis of metastatic skin carcinoma [J]
-
Claerhout S, Verschooten L, Van Kelst S, et al. Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-in duced apoptosis of metastatic skin carcinoma [J]. Int J Cancer, 2010,127(12):2790-2803.
-
(2010)
Int J Cancer
, vol.127
, Issue.12
, pp. 2790-2803
-
-
Claerhout, S.1
Verschooten, L.2
van Kelst, S.3
-
19
-
-
71749096160
-
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies [J]
-
Solomon VR, Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies [J]. Eur J Pharmacol, 2009,625(1-3):220-233.
-
(2009)
Eur J Pharmacol
, vol.625
, Issue.1-3
, pp. 220-233
-
-
Solomon, V.R.1
Lee, H.2
|